Julie Grisham, MS

Freelance Science Writer

Recent Blog Posts

Pictured: Megan Harlan Fleischut & Kenneth Offit
Q&A
Monday, April 15, 2013

Genetic counselor Megan Harlan Fleischut discusses hereditary cancers and the services offered by Memorial Sloan Kettering’s clinical genetics experts.

Pictured: Virtual Programs
Event
Friday, April 12, 2013

Memorial Sloan Kettering’s Virtual Programs offers patients private, online support and education sessions to participate in from home or work.

Pictured: José Baselga
Finding
Monday, April 8, 2013

Memorial Sloan Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.

Pictured: Kenneth Offit
Finding
Thursday, March 28, 2013

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.

Pictured: ESK1 Monoclonal Antibody
In the Lab
Wednesday, March 13, 2013

Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Pictured: Massage Therapy
In the Clinic
Monday, March 4, 2013

Peripheral neuropathy — a nerve disorder that can cause weakness, numbness, tingling, and pain — is a common chemotherapy side effect. Treatments are available to help improve your quality of life.

Pictured: Major Trends in Modern Cancer Research Seminar
Video
Friday, March 1, 2013

At the seventh annual seminar for high school students and teachers, investigators discuss how cutting-edge biomedical research may ultimately contribute to better treatments for cancer patients.

Pictured: Prasad Adusumilli
In the Lab
Thursday, January 3, 2013

A team from Memorial Sloan Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.

Pictured: Tim Ahles
Q&A
Thursday, December 27, 2012

Problems with cognitive function can significantly impact a person’s quality of life after cancer treatment. New research is focused on the link between cancer treatment and cognitive changes.

Pictured: Michel Sadelain
In the Lab
Tuesday, December 18, 2012

Memorial Sloan Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

In the News
Friday, November 16, 2012

Memorial Sloan Kettering has been praised for taking a stand on the price for a new cancer drug that costs more than twice as much as another, similar drug.

Pictured: Ping Chi
Q&A
Friday, November 2, 2012

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

Pictured: Structure of Synthesized Erythropoietin
In the Lab
Monday, October 8, 2012

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.

Pictured: Richard Barakat
Honor
Monday, October 1, 2012

Dr. Barakat will serve as president of two prestigious societies for gynecologic cancer, allowing him to influence how women with these cancers are cared for both in the United States and around the world.

Pictured: Alexander Rudensky
Announcement
Wednesday, September 26, 2012

Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.